In 2025, cardiologists and cardiac surgeons at NewYork-Presbyterian led breakthroughs that impacted a range of diseases and conditions from advanced heart failure to pediatric valve disease. Physicians and researchers from Columbia and Weill Cornell Medicine pioneered the use of artificial intelligence to identify structural heart disease, launched a mobile app to expand access to heart failure education, performed one of the first split-root domino partial heart transplants, and more. Our experts remained at the forefront of innovative, multidisciplinary care, delivering comprehensive treatment for the most complex cardiac diseases.
Our world-renowned Columbia and Weill Cornell Medicine physicians and surgeons in our comprehensive cardiology, heart surgery, and vascular programs spearhead groundbreaking clinical and scientific research and provide the most innovative treatments to optimize patient outcomes for all stages of disease complexity. Our clinicians are experts in minimally invasive approaches and novel therapeutics for all types of heart disease and work across disciplines to provide compassionate care to all patients.
Cardiology & Heart Surgery
Featured Updates
On this episode of Advances in Care, Dr. Steven Lobritto, pediatric medical director for liver transplant at NewYork-Presbyterian and Columbia, joins host Erin Welsh to tell the story of a high-risk pediatric liver transplant that he and his team performed to save the life of a two month old baby, after the center where the baby was originally treated deemed her inoperable.
The Latest










